环球医疗(02666.HK)上半年营收75.81亿元 纯利同比增长8.0%至12.28亿元
格隆汇8月27日丨环球医疗(02666.HK)公布中期业绩,2025年上半年,截至2025年6月30日止六个月,收入约人民币7,580.7百万元,较2024年同期的约人民币6,542.7百万元增长15.9%;公司普通股权益持有人应占期内溢利约人民币1,228.1百万元,较2024年同期的约人民币1,137.2百万元增长8.0%。
于2025年6月30日,总资产约人民币85,716.6百万元,较于2024年12月31日的约人民币86,032.3百万元减少0.4%。于2025年6月30日,公司普通股权益持有人应占权益约人民币17,703.4百万元,较于2024年12月31日的约人民币17,175.7百万元增长3.1%。截至2025年6月30日止六个月,股本回报率为14.08%。截至2025年6月30日止六个月,总资产回报率为3.11%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.